1Andressen C, Henseler T. Inheritance of psoriasis. Analysis of 2035 family histories. Hautarzt, 1982, 33 (4) :214 - 217.
2Capon F, NovelliG, Semprini S, et al. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol, 1999, 112 ( 1 ) :32 - 35.
3Cheng L, Zhang SZ, Xiao CY, et al. The A5. 1 allele of the major histocompatibility complex class I chain-related gene A is associated with psoriasis vulgaris in Chinese. Br J Dermatol, 2000, 143 (2) :324- 329.
4Schon MP. Animal models of psoriasis - what can we learn from them? J Invest Dermatol, 1999, 112(4) :405 -410.
5Roses AD. Pharmacogenetics and the practice of medicine. Nature, 2000, 405(6788) :857 -865.
6Magilavy D. Immunopharmacologic effects of Amevive (LFA3-TIP) in chronic plaque psoriasis: selectivity for peripheral memory effector (CD45 RO + over naive CD45 RA + ) T cells. Br J Dermatol,1999, 141:990 (Abstr).
7Mrowietz U, Zhu K, Christophers E. Treatment of severe psoriasis with anti - CD25 monoclonal antibodies. Arch Dermatol, 2000, 136(5) :675 -676.
8Asadullah K, Sabat R, Wiese A, et al. Interleukin - 10 in cutaneous disorders: implications for its pathophysiological importance and therapeutic use. Arch Dermatol Res, 1999, 291 (12) :628 -636.
9Prinz JC, Vollmer S, Boehncke WH, et al. Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris. Eur J Immunol, 1999, 29 ( 10 ):3360 - 3368.
10Menssen A, Trommler P, Vollmer S, et al. Evidence for an antigenspecific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol, 1995, 155 ( 8 ) :4078 - 4083.
